Clinical Trial Update: Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating memantine for prevention of oxaliplatin-induced peripheral neurotoxicity in cancer patients (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Mansoura University | Conditions: Cancer | Phase 1, Phase 2 | Status: UNKNOWN